NxStage Extends Supply Agreement with B. Braun Medical Inc. to Include Streamline(R) ...( LAWRENCE Mass. June 1 /- NxStage Medi...),Health

LAWRENCE, Mass., June 1 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that its Medisystems in-center business has completed development of the new Streamline blood tubing sets for use on the B. Braun Dialog(R) and Dialog Plus hemodialysis systems in the U.S. In connection with this development, NxStage and B. Braun have agreed to extend their supply agreement under which NxStage will supply B. Braun with the new Streamline sets and B. Braun will provide sales, marketing, and clinical support to its U.S. customers.

"The launch of Streamline for the B. Braun machines broadens our relationship and extends the value of our product portfolio to B. Braun's Renal Therapies Division giving patients and providers greater access to NxStage's high quality, value-added in-center offerings," said Jeffrey H. Burbank, President and Chief Executive Officer of NxStage Medical. "Streamline's ability to improve patient clearances and reduce cost is yet another example of NxStage's ability to innovate and bring value in the form of both clinical benefits and operational savings."

"We are pleased to broaden our relationship with NxStage by offering the unique Streamline technology to our dialysis customers," stated Samuel Amory, Vice President, B. Braun Medical Renal Therapies Division. "We look forward to leveraging Streamline's benefits with our state-of-the-art Dialog hemodialysis system and growing our business with NxStage."

NxStage's latest generation blood tubing set is the Streamline. Streamline features an efficient and airless design intended to improve clinical and economic performance. Streamline is designed to reduce dialysate flow, dialyzer size, treatment time, minimize heparin and waste, and optimize dose delivery, as m
'/>"/>